Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-07

Clinical Trial Update: The Safety and Immunogenicity of a Potential HIV Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immunogenicity of a potential HIV vaccine; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2019-11-07